Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CEBPA Mutation”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04415008
What this trial is testing

Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia

Who this might be right for
CEBPA Double MutationAcute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 61
Testing effectiveness (Phase 2)Looking for participantsNCT07451912
What this trial is testing

Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML

Who this might be right for
Acute Myeloid Leukemia (AML)CEBPA MutationUnfit, New-diagnosis AML
The First Affiliated Hospital of Soochow University 29
Not applicableStudy completedNCT01057199
What this trial is testing

Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 6
Not applicableLooking for participantsNCT06529250
What this trial is testing

Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 148